Long-term prognostic value of elevated pentraxin 3 in patients undergoing primary angioplasty for ST-elevation myocardial infarction

Akgul, Ozgur; Baycan, Omer; Bulut, Umit; Somuncu, Mustafa; Pusuroglu, Hamdi; Ozyilmaz, Sinem; Gul, Mehmet; Demir, Ali; Yilmaz, Emre; Yazan, Serkan; Kokturk, Ugur; Cetin, Ilyas; Uyarel, Huseyin

doi:10.1097/mca.0000000000000280

Long-term prognostic value of elevated pentraxin 3 in patients undergoing primary angioplasty for ST-elevation myocardial infarction

Copy For Citation

Akgul O., Baycan O. F., Bulut U., Somuncu M. U., Pusuroglu H., Ozyilmaz S., ...More

CORONARY ARTERY DISEASE, vol.26, no.7, pp.592-597, 2015 (SCI-Expanded)

Publication Type: Article / Article
Volume: 26 Issue: 7
Publication Date: 2015
Doi Number: 10.1097/mca.0000000000000280
Journal Name: CORONARY ARTERY DISEASE
Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Page Numbers: pp.592-597
Bezmialem Vakıf University Affiliated: Yes

Abstract

Objectives The prognostic value of pentraxin 3 (PTX3) has been documented in patients with acute coronary syndrome. However, its long-term prognostic value in acute ST-segment elevation myocardial infarction (STEMI) remains unclear. The aim of this study was to evaluate the prognostic value of PTX3 in patients with STEMI undergoing a primary percutaneous coronary intervention (PCI).